A patient with severe thiazide-induced hyponatraemia (plasma sodium 99 mmol/l) is described, who had signs suggestive of cerebral oedema. Co-existent problems of cardiac and respiratory insufficiency were thought to make treatment with hypertonic saline hazardous. A 40-hr peritoneal dialysis successfully reversed both hyponatraemia and the associated cerebral signs, plasma sodium increasing at a rate of 0-83 mmol/hr. Peritoneal dialysis appears to be a safe and efficacious method of treating severe thiazideinduced hyponatraemia.
Introduction
Hyponatraemia may occasionally be of such severity as to cause disturbance of consciousness and threaten life. In such circumstances conventional therapy with water deprivation or demeclocycline may be too slow and patients with cardiac, respiratory or renal insufficiency may be at risk from the infusion of hypertonic saline. The authors now report the use of peritoneal dialysis to reverse severe hyponatraemia.
Case report
The patient was a 62-year-old Edinburgh man whose previous history included emphysema and hypertension. His The chest X-ray and electrocardiogram showed changes typical of severe bullous emphysema with pulmonary arterial hypertension. A 9 a.m. plasma cortisol was elevated (1089 nmol/l). Computerized tomography of the brain revealed an extensive leftsided occipital infarct.
In view of his hypertension, renal, cardiac and pulmonary insufficiency it was decided that hypertonic saline infusion would be too hazardous and so it was decided to dialyse him. Peritoneal dialysis was begun with a dialysate containing glucose 75 6 mmol/l (13-6 g/l), sodium 140 mmol/l and potassium 4-4 mmol/l and continued for 40 hr. Dialysis induced a negative fluid balance and corrected the hyponatraemia, plasma sodium rising at the rate of 0-83 mmol/l/hr. (Fig. 1 ). His BP fell during dialysis to 110/60 mmHg but his urine output was maintained at an average 40 mil/hr. The hypokalaemia was unaffected by peritoneal dialysis, despite increasing the dialysate potassium to 5 mmol/l. Spironolactone, 50 mg daily, was given from the third day of his admission and corrected the hypokalaemia.
Following the correction of hyponatraemia his conscious level improved and the neurological signs resolved. He developed a chest infection and respiratory failure 3 days after admission but this was successfully treated with positive pressure ventilation, physiotherapy and antibiotics. A further chest infection and respiratory failure developed 10 days later, but by this time detailed knowledge of the severity of his chest disease had been received from Edinburgh and it was decided not to ventilate him again. He died 17 days after admission. A post-mortem examination revealed severe bullous emphysema with broncho-pneumonia and right ventricular hypertrophy, and confirmed the occipital lobe infarction. There was no evidence of malignancy. (Fichman et al., 1971) .
Whatever the cause of his hyponatraemia, it was apparent that it required correction. The occurrence of cerebral signs in hyponatraemia is thought to be related to intracellular electrolyte disturbances and cerebral oedema, and is associated with a high mortality (Arieff et al., 1976 developed over a short period, clearly had severe cerebral signs. Controversy exists over the rate at which hyponatraemia should be reversed in these circumstances.
There is concern that too rapid a reduction of brain swelling may cause cerebral venous bleeding (Levin, 1978 (Thomas et al., 1978) . 
